Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän

Visfatin is an adipokine,… - Göteborgs universitet Till startsida
Till innehåll Läs mer om hur kakor används på gu.se

Visfatin is an adipokine, but it is not regulated by thiazolidinediones

Artikel i vetenskaplig tidskrift
Författare Ann Hammarstedt
J. Pihlajamaki
Victoria Rotter Sopasakis
Silvia Gogg
Per-Anders Jansson
M. Laakso
Ulf Smith
Publicerad i J Clin Endocrinol Metab
Volym 91
Nummer/häfte 3
Sidor 1181-4
ISSN 0021-972X (Print)
Publiceringsår 2006
Publicerad vid Institutionen för medicin, avdelningen för molekylär och klinisk medicin
Sidor 1181-4
Språk en
Länkar www.ncbi.nlm.nih.gov/entrez/query.f...
Ämnesord Adipose Tissue/drug effects/*metabolism, Cytokines/*genetics, Diabetes Mellitus, Type 2/*drug therapy, Female, Gene Expression Regulation/drug effects, Glucose Clamp Technique, Humans, Hypoglycemic Agents/therapeutic use, Male, Middle Aged, Reference Values, Thiazolidinediones/*therapeutic use
Ämneskategorier Medicin och Hälsovetenskap


CONTEXT: Visfatin was recently reported to be expressed in human adipose tissue and to exert insulin-mimicking effects. OBJECTIVE: The objective of this study was to examine whether visfatin is a true adipokine and is expressed in isolated fat cells. We also examined whether visfatin is regulated by thiazolidinediones and, thus, can contribute to the ability of these agents to improve insulin sensitivity. DESIGN: This was an open-labeled drug therapy trial. SETTING: This study was performed at a university hospital. PATIENTS: Seven newly diagnosed and previously untreated type 2 diabetic patients and six healthy individuals with reduced insulin sensitivity participated in the study. INTERVENTION: Pioglitazone therapy (30-45 mg/d) was given for 3-4 wk. MAIN OUTCOME MEASURES: Serum and adipose tissue mRNA levels of visfatin and adiponectin were the main outcome measures. RESULTS: Visfatin mRNA is expressed in both adipose tissue and isolated adipocytes. Treatment with thiazolidinediones for 3-4 wk did not alter the gene expression or circulating levels of visfatin in either nondiabetic or the diabetic individuals, whereas adiponectin increased significantly. CONCLUSION: The present study shows that visfatin is a true adipokine, but it is not regulated by TZD and, thus, is unlikely to contribute to the insulin-sensitizing actions of these drugs.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?